CI Investments Inc’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-345
Closed -$69K – 690
2025
Q3
$69K Sell
345
-281
-45% -$52.4K ﹤0.01% 955
2025
Q2
$108K Sell
626
-29
-4% -$4.72K ﹤0.01% 891
2025
Q1
$102K Sell
655
-450
-41% -$64.3K ﹤0.01% 903
2024
Q4
$152K Sell
1,105
-150
-12% -$19.7K ﹤0.01% 818
2024
Q3
$187K Sell
1,255
-96
-7% -$13K ﹤0.01% 678
2024
Q2
$184K Sell
1,351
-117
-8% -$15.9K ﹤0.01% 648
2024
Q1
$222K Buy
1,468
+678
+86% +$96.8K ﹤0.01% 673
2023
Q4
$100K Sell
790
-158
-17% -$15.8K ﹤0.01% 834
2023
Q3
$89K Sell
948
-144
-13% -$13.5K ﹤0.01% 844
2023
Q2
$97K Buy
1,092
+600
+122% +$52.2K ﹤0.01% 790
2023
Q1
$53K Buy
492
+410
+500% +$46.9K ﹤0.01% 886
2022
Q4
$10K Buy
82
+8
+11% +$929 ﹤0.01% 1130
2022
Q3
$8K Sell
74
-8
-10% -$758 ﹤0.01% 1139
2022
Q2
$8K Sell
82
-203
-71% -$19.1K ﹤0.01% 1048
2022
Q1
$33K Sell
285
-17
-6% -$1.97K ﹤0.01% 1018
2021
Q4
$41K Buy
302
+70
+30% +$10.4K ﹤0.01% 1026
2021
Q3
$37K Buy
+232
New +$31.8K ﹤0.01% 1006

Other funds holding ASND

CI Investments Inc's ASND Position: Q4 2025 in Review

CI Investments Inc sold out of Ascendis Pharma A/S (ASND) in Q4 2025, closing a stake of 345 shares — an estimated $69K sold.

CI Investments Inc first reported a position in ASND in Q3 2021 and held it in 17 quarters. The position peaked at $222K in Q1 2024. 302 funds tracked by Wall St. Rank hold ASND as of Q4 2025.

  • CI Investments Inc reported no remaining Ascendis Pharma A/S position as of Q4 2025 after selling out during the quarter.
  • CI Investments Inc sold 345 Ascendis Pharma A/S shares in Q4 2025, an estimated $69K.
  • CI Investments Inc first reported a position in Ascendis Pharma A/S in Q3 2021 and held it in 17 quarters.
  • CI Investments Inc's Ascendis Pharma A/S position peaked at $222K in Q1 2024.
  • 302 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2025.

Based on CI Investments Inc's 13F filing for Q4 2025, filed 12 Feb 2026.